Abstract
• Background: Nitric oxide synthase (NOS) is present in many ocular tissues where it may have different physiological functions. This warrants a thorough characterization of NOS activity in the eye. • Methods: NOS distribution and its biochemical properties were determined in the retina, choroid, ciliary processes (CP), and trabecular meshwork (TM). • Results: Retinal NOS required NADPH (diphenyleneiodonium, a flavoprotein inhibitor, which inhibited enzyme activity with an IC50 of 0.36 μM, FAD (40 μM), FMN (40 μM), and BH4 (4 μM) as cofactors for optimal activity. Ocular NOS appeared to be regulated by free divalent cations, since its activity was inhibited by EDTA (slopes >3.0 and IC50 values of 12.8, 19.7, and 53 μM, respectively). Ocular NOS required calmodulin, since NOS activity was inhibited by trifluoperazine (calmodulin inhibitor, IC50=41 μM). NOS activity is widely distributed in the eye, (choroid >reinta >CP >TM) and is mainly cytosolic (70–95%).l-Arginine analogs inhibited NOS in the retina, choroid, and TM. In all three tissues,N G-methyl-l,-arginine displayed the highest affinity for inhibition (IC50=0.2–0.7 μM) followed by canavanine (IC50=13–33 μM), while aminoguanidine only weakly inhibited NOS (IC50=93–179 μM). • Conclusion: In all tissues, the order of potency of inhibition points to the presence of constitutive rather than inducible NOS. Moreover, it is possible that TM contains more than a single form of NOS.
Similar content being viewed by others
Abbreviations
- AG :
-
Aminoguanidine,
- BH 4 :
-
tetrahydrobiopterin
- CAM :
-
calmodulin
- CAN :
-
canavanine
- CP :
-
ciliary processes
- DPI :
-
diphenyliodonium
- EDTA :
-
ethylenediamine tetraacetic acid
- FAD :
-
flavin adenine dinucleotide
- FMN :
-
flavin mononucleotide
- IOP :
-
intraocular pressure
- L-NNA :
-
N w-nitro-l.-arginine
- NADPH :
-
B-nicotinamide adenine dinucleotide phosphate
- NMMA :
-
N G-methyl-l-arginine
- NO :
-
nitrix oxide
- NOS :
-
nitric oxide synthase
- RPE :
-
retinal pigment epithelium
- TFP :
-
trifluoperazine
- TM :
-
trabecular meshwork
References
Ahmad I, Leinders-Zufall T, Kocsis JD, Shepherd GM, Zufall F, Barnstable CJ (1994) Retinal ganglion cells express a cGMP-gated cation conductance activatable by nitric oxide donors. Neuron 12:155–165
Anderson PJ, Wang J, Epstein D (1980) Metabolism of calf trabecular (reticular) meshwork. Invest Ophthalmol Vis Sci 19:13–20
Bechar-Cohen FF, Goureau O, D'Hermies F, Courtois Y (1996) Decreased intraocular pressure induced by nitric oxide donors is correlated to nitric oxide production in the rabbit eye. Invest Ophthalmol Vis Sci 37:1711–1715
Becquet F, Yapo A, Courtois Y, Gouzou O (1996) NO synthase expression in RCS rat retina. (abstract) Invest Ophthalmol Vis Sci 37:2897
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Bredt DS, Snyder SH (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86:9030–9033
Busse R, Mulsch A (1990) Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett 265:133–138
Chiou GC, Liu SX, Li BH, Chiang CH, Varma RS (1995) Ocular hypotensive effects ofl-arginine and its derivatives and their actions on ocular blood flow. J Ocul Pharmacol Ther 11:1–10
Dawson TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH (1991) Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA 88:7797–7801
Deussen A, Sonntag M, Vogel R (1993)l-Arginine-derived nitric oxide: a major determinant of uveal blood flow. Exp Eye Res 57:129–134
Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA (1996) Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 114:299–305
Fisher LJ, Guerin CJ, Schiffman RM (1996) Nitric acid synthase is located in the epithelia of the ciliary processes (abstract). Invest Ophthalmol Vis Sci 37:3872
Forstermann U, Gorsky LD, Pollock JS, Ishii K, Schmidt HH, Heller M, Murad F (1990) Hormone-induced biosynthesis of endothelium-derived relaxing factor/nitric oxide-like material in N1E-115 neuroblastoma cells requires calcium and calmodulin. Mol Pharmacol 38:7–13
Forstermann U, Pollock JS, Schmidt HH, Heller M, Murad R (1991) Calmodulin-dependent endotheliumerived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci USA 88:1788–1792
Forstermann U, Pollock JS, Nakane M (1993) Nitric oxide synthase in the cardiovascular system. Trends Cardiovasc Med 3:104–110
Forstermann U, Gath I, Schwarz P, Closs EI, Kleinert H (1995) Isoforms of nitric oxide synthase. Properties, cellular idstribution and expressional control. Biochem Pharmacol 50:1321–1332
Geyer O, Almog J, Lupo-Meiri M, Lazar M, Oron Y (1995) Nitric oxide synthase inhibitors protect rat retina against ischernic injury. FEBS Lett 374:399–402
Geyer O, Podos SM, Mittag TW (1993) Nitric oxide synthase: distribution and biochemical properties of the enzyme in bovine eyes. (abstract) Invest Ophthal Vis Sci 34:826
Goureau O, Lepoivre M, Mascarelli F, Courtois Y (1992) Nitric oxide synthase activity in bovine retina. Struct Funct Retin Prot 221:395–398
Greenstreet EH, Djamgoz MB (1994) Nitric oxide induces light adaptive morphological changes in retinal neurons. Neuroreceptor 6:109–112
Hauschildt S, Luckhoff A, Mulsch A, Kohler J, Bessler W, Busse R (1990) Induction and activity of NO synthase in bone-marrow-derived macrophages are independent of Ca2+. Biochem J 270:351–355
Hiki K, Yui Y, Hattori R, Eizawa H, Kosuga K, Kawai C (1991) Three regulation mechanisms of nitric oxide synthase. Eur J Pharmacol (Mol Pharmacol) 206:163–164
Jason G, Samsel U, Samsel RW (1992)l-Canavanine selectively augments contraction in aortas from endotoxemic rats. Eur J Pharmacol 210:343–346
Koch KW, Lambrecht HG, Haberecht M, Redbum D, Schmidt HH (1994) Functional coupling of a Ca2+/calmodulin-dependent nitric oxide synthase and a soluble guanylyl cyclase in vertebrate photoreceptor cells. EMBO J 13:3312–3320
Liversidge J, Grabowski P, Ralston S, Benjamin N, Forrester JV (1994) Rat retinal pigment epithelial cells express an inducible form of nitric oxide synthase and produce nitric oxide in re sponse to inflammatory cytokines and activated T cells. Immunology 83:404–409
Mann RM, Riva CE, Stone RA, Barnes GE, Granstoun SD (1995) Nitric oxide and choroidal blood flow regulation. Invest Ophthalmol Vis Sci 36:925–930
Mayer B, Scmidt K, Humbert P, Bohme E (1989) Biosynthesis of endotheliumderived relaxing factor: a cytosolic enzyme in porcine aortic endothelial cell Ca2+-dependently convertsl-arginine into an activator of soluble guanylyl cyclase. Biochem Biophys Res Commun 164:678–685
Mayer B, John M, Bohme E (1990) Purification of Ca2+/calmodulin-depen-dent nitric oxide synthase from porcine cerebellum. Cofactor-role of tetrahydrobiopterin. FEBS Lett 277:215–217
Mayer B, Mathias J, Heinzel B, Werner ER, Wachter H, Schultz G, Bohme E (1991) Brain nitric oxide synthase in a biopterin and flavin-containing multifunctional oxido-reductase. FEBS Lett 288:187–191
Misto TP, Moore WM, Kasten TP, Nickols DA, Carbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG (1993) Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233:119–125
Nathanson JA (1988) Direct application of a guanylate cyclase activator lowers intraocular pressure. Eur J Pharmacol 147:155–156
Nathanson JA (1992) Nitrovasodilators as a new class of ocular hypertensive agents. J Pharmacol Exp Ther 260:956–965
Nathanson JA, McKee M (1995a) Identification of an extensive system of nitric oxide-producing cells in the ciliary muscle and outflow pathway of the human eye. Invest Ophthalmol Vis Sci 36:1765–1773
Nathanson JA, McKee M (1995b) Alterations of ocular nitric oxide synthase in human glaucoma. Invest Ophthalmol Vis Sci 36:1774–1784
Noll GN, Billek M, Pietruck C, Schmidt KF (1994) Inhibition of nitric oxide synthase alters light responses and dark voltage of amphibian photoreceptors. Neuropharmacology 33:1407–1412
Osborne NN, Barnett NL, Herrera AJ (1993) NADPH diaphorase localization and nitric oxide synthetase activity in the retina and anterior uvea of the rabbit eye. Brain Res 610:194–198
Perez MRT, Larsson B, Alm P, Ehinger B (1995) Localization of neuronal nitric oxide synthase-immunoreactivity in rat and rabbit retinas. Exp Brain Res 104:207–217
Schmidt HH, Pollock JS, Nakane M, Gorsky LD, Forstermann U, Murad R (1991) Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase. Proc Natl Acad Sci USA 88:365–369
Schnetkamp PPM, Klompmakers AA, Daemen FJM (1979) The isolation of stable cattle rod outer segments with an intact plasma membrane. Biochem Biophys Acta 552:379–389
Southan GJ, Szabo C (1996) Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Biopharmacol 51:383–394
Stuehr DJ, Swon NS, Nathan CF (1990) FAD and GSH participate in macrophage synthesis of nitric oxide. Biochem Res Commun 168:558–565
Venturini CM, Knowles RG, Palmer RM, Moneada S (1991) Synthesis of nitric acid in the bovine retina. Biochem Biophys Res Commun 180:920–925
Wiederholt M, Sturm A, Lepple-Wienhues A (1994) Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest Ophthalmol Vis Sci 35:2515–2520
Yamamoto R, Bredt DS, Snyder SH, Stone RA (1993) The localization of nitric oxide synthase in the rat eye and related cranial ganglia. Neuroscience 54:189–200
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Geyer, O., Podos, S.M. & Mittag, T. Nitric oxide synthase activity in tissues of the bovine eye. Graefe's Arch Clin Exp Ophthalmol 235, 786–793 (1997). https://doi.org/10.1007/BF02332864
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02332864